Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. electrosurgery
Show results for
Products
Services
Applications

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • Older

Electrosurgery Articles & Analysis

14 news found

The next evolution in blood vessel occlusion

The next evolution in blood vessel occlusion

The good news for his patient was that she was young. A lower extremity bypass procedure - like any surgery - can be more difficult as we age. The bad news was that the best veins for the procedure - which involves grafting a vein from another part of the body to bypass her blocked arteries in the leg - were unusable. The patient had undergone varicose vein treatments as a young woman that ...

ByAmsel Medical Corporation


USMI and JCRI Research Teams Develop Treatment System for COVID and other Respiratory Infections and Diseases

USMI and JCRI Research Teams Develop Treatment System for COVID and other Respiratory Infections and Diseases

US Medical Innovations, LLC (USMI) and the Jerome Canady Research Institute for Advanced and Biological Technological Sciences (JCRI-ABTS) announced today that the United States Patent and Trademark Office has issued a Notice of Allowance in connection with JCRI-ABTS’s US National Stage Application (Serial No. 17/284,762) entitled “SYSTEM FOR TREATMENT OF RESPIRATORY INFECTIONS AND ...

ByUS Medical Innovations, LLC


USMI to Announce Successful Results of Phase I Clinical Trial Using Cold Atmospheric Plasma for the Treatment of Solid Tumors at the Baird 2021 Global Healthcare Conference

USMI to Announce Successful Results of Phase I Clinical Trial Using Cold Atmospheric Plasma for the Treatment of Solid Tumors at the Baird 2021 Global Healthcare Conference

US Medical Innovations, LLC (USMI), a U.S. FDA-registered life-science and biomedical device company and the Jerome Canady Research Institute for Advanced and Biological Technological Sciences (JCRI-ABTS) announced today that Jerome Canady MD, CEO will be presenting at the Baird Global Healthcare Conference on Tuesday, September 14th from 10:15 to 10:45 AM ET. Dr. Canady will present results ...

ByUS Medical Innovations, LLC


JCRI Discovers the Mechanism using Canady Helios Cold Plasma to Induce Cell Death in Breast Cancer

JCRI Discovers the Mechanism using Canady Helios Cold Plasma to Induce Cell Death in Breast Cancer

The Jerome Canady Research Institute for Advanced Biological and Technological Sciences (JCRI-ABTS), in collaboration with US Medical Innovations, LLC (USMI), announced today that they have discovered the mechanism using Canady Helios™ Cold Plasma (CHCP) to induce cell death in breast cancer. Recently accepted for publication in the International Journal of Molecular Sciences, the article ...

ByUS Medical Innovations, LLC


JCRI-ABTS and USMI Successfully Complete Phase 1 Multi-Center Clinical Trial Using Canady Helios™ Cold Plasma for the Treatment of Cancer

JCRI-ABTS and USMI Successfully Complete Phase 1 Multi-Center Clinical Trial Using Canady Helios™ Cold Plasma for the Treatment of Cancer

The Jerome Canady Research Institute for Advanced Biological and Technological Sciences, LLC (JCRI-ABTS) and US Medical Innovations, LLC (USMI) announced today that they have successfully completed Phase 1 in their Clinical Trial using Canady Helios™ Cold Plasma (CHCP) for the treatment of recurrent and stage 4 solid tumors (IDE #G190195). The medical centers involved in the study were Rush ...

ByUS Medical Innovations, LLC


DermBiont Announces Acquisition of SeylanMED to Expand its Portfolio of Targeted Topical Therapeutics Treating Skin Diseases at Their Root Cause

DermBiont Announces Acquisition of SeylanMED to Expand its Portfolio of Targeted Topical Therapeutics Treating Skin Diseases at Their Root Cause

The current standard of care is ablation with curettage, an effective treatment, but with several side effects including scarring, changes in pigmentation, pain, bleeding, and risk of wound infection; alternative treatments include electrosurgery or cryosurgery, which are not as effective as curettage. These procedures are costly, must be performed by a provider at a clinic, and ...

ByDermBiont, Inc.


First Patients Treated with Galaxy Medical’s CENTAURI Pulsed Electric Field Cardiac Ablation System

First Patients Treated with Galaxy Medical’s CENTAURI Pulsed Electric Field Cardiac Ablation System

MENLO PARK, California, October 9, 2020 — Galaxy Medical, (Galaxy), a developer of Pulsed Electric Field (PEF) technology for the treatment of cardiac arrhythmias, today announced that the first patients were successfully treated with the proprietary CENTAURI™ System by Dr. Ante Ani in Split, Croatia as part of the ECLIPSE-AF study. This multicenter trial is designed to assess the ...

ByGalvanize Therapeutics, Inc.


Large Complex Polyps Removed Successfully From Three Patients Without Surgical Intervention Using Lumendi Dilumen C2

Large Complex Polyps Removed Successfully From Three Patients Without Surgical Intervention Using Lumendi Dilumen C2

A large complex sigmoid polyp in a 62-year-old male patient was successfully removed in a 60-minute procedure without surgical intervention using DiLumen C2, a second-generation endoscopic dual balloon colon stabilization accessory that employs two 6mm working channels that accommodate several flexible therapeutic instruments designed to efficiently retract and dissect tissue. The endolumenal ...

ByLumendi Ltd.


Lumendi Receives 510(K) Clearance for Dilumen Ik Endolumenal Interventional Knife

Lumendi Receives 510(K) Clearance for Dilumen Ik Endolumenal Interventional Knife

Connecticut-based medical device innovator Lumendi, LLC (http://www.lumendi.com) has announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the DiLumen Ik™ Endolumenal Interventional Knife, a sterile, single-use, disposable monopolar electrosurgical device for cutting, dissecting, and cauterizing tissue within the digestive tract during endoscopic procedures. ...

ByLumendi Ltd.


Startup Licenses UA-Invented Disruptive Biopsy Device

Startup Licenses UA-Invented Disruptive Biopsy Device

The University of Arizona has licensed the design for a next-generation needle biopsy instrument that utilizes electrosurgery and electrocautery to safely increase tissue sample volumes in minimally invasive biopsy procedures. ...

ByData Driven Diagnostic Sciences (D3Sciences)


Olympus Extends Portfolio of EndoTherapy Solutions at DDW

Olympus Extends Portfolio of EndoTherapy Solutions at DDW

Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, among other core businesses, announced today the availability of several new endoscopic therapeutic devices, to be unveiled at the upcoming Digestive Disease Week conference May 6-9 in Chicago, Ill. The expansion of the market leading offerings is a signal of the Olympus ...

ByHSM GmbH Co. KG


Plasma Surgical Proudly Supports 2015 SAGES Annual Meeting with Presented Abstracts by Thought Leaders

Plasma Surgical Proudly Supports 2015 SAGES Annual Meeting with Presented Abstracts by Thought Leaders

Roswell, Georgia – April 15, 2015, – Plasma Surgical, creator of the PlasmaJet® Surgery System, an advanced energy-based medical device designed as a safe and effective alternative to traditional electrosurgery and other instruments, is pleased to recognize Professor Horace Roman’s presentations at the 2015 SAGES Conference in Nashville, Tennessee. ...

ByPlasma Surgical, Inc.


Plasma Surgical Names Steve Gulick Senior Vice President of North American Sales & Business Development

Plasma Surgical Names Steve Gulick Senior Vice President of North American Sales & Business Development

Plasma Surgical Names Steve Gulick Senior Vice President of North American Sales & Business Development Industry veteran brings 20 years of surgical technology sales experience Roswell, Georgia – November 1, 2014 – Plasma Surgical, creator of the PlasmaJet® Surgery System, an energy-based medical device designed as a safe and effective alternative to traditional ...

ByPlasma Surgical, Inc.


Plasma Surgical Announces Expanded Indications for Use for the PlasmaJet® Surgery System

Plasma Surgical Announces Expanded Indications for Use for the PlasmaJet® Surgery System

– May 1, 2013 – Plasma Surgical, creator of the PlasmaJet®, an advanced energy medical device designed as a safe and effective alternative to traditional electrosurgery instruments, announced today that it has received 510(k) clearance from the U.S. ...

ByPlasma Surgical, Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT